Population
preclinical adult heart model
Design
Preclinical
Authors
Loading...
Offers novel preclinical arrhythmia target; leaves open translation to human therapy.
Preclinical evidence suggests TBX5 protein normalization may be a novel therapeutic strategy for arrhythmia control.
Rathjens et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: